-
Product Insights
NewLikelihood of Approval Analysis for Metastatic Prostate Cancer
Overview How likely is it that the drugs in Metastatic Prostate Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Metastatic Prostate Cancer Overview Metastatic prostate cancer occurs when cancerous cells...
-
Product Insights
NewLikelihood of Approval Analysis for Hormone-Sensitive Prostate Cancer
Overview How likely is it that the drugs in Hormone-Sensitive Prostate Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hormone-Sensitive Prostate Cancer Overview Hormone-sensitive prostate cancer (HSPC) is a type...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Small Molecule To Target PSMA For Metastatic Hormone Refractory Prostate Cancer in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Small Molecule To Target PSMA For Metastatic Hormone Refractory Prostate Cancer in Metastatic Castration-Resistant Prostate Cancer (mCRPC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Rintatolimod in Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rintatolimod in Prostate Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rintatolimod in Prostate Cancer Drug Details: Ampligen is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Toripalimab in Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Toripalimab in Prostate Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Toripalimab in Prostate Cancer Drug Details: Toripalimab (Tuoyi, Loqtorzi) is a...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Estetrol in Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Estetrol in Prostate Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Estetrol in Prostate Cancer Drug Details: Esterol (E-4) is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Pyrimethamine in Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pyrimethamine in Prostate Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pyrimethamine in Prostate Cancer Drug Details: Pyrimethamine (GLG-801) is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Tinengotinib in Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tinengotinib in Prostate Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tinengotinib in Prostate Cancer Drug Details: TT-00420 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Ecubectedin in Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ecubectedin in Prostate Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ecubectedin in Prostate Cancer Drug Details: Ecubectedin (PM-14) is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Tempol in Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tempol in Prostate Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tempol in Prostate Cancer Drug Details: Tempol is under development for the...